Clariane SE

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0010386334
EUR
3.58
-0.1 (-2.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Clariane SE stock-summary
stock-summary
Clariane SE
Pharmaceuticals & Biotechnology
Korian SA, formerly Korian Medica SA, is a France-based company that operates healthcare facilities and medical establishments. The Company's holdings include residential centers for the elderly, offering permanent social care and medical support; follow-up care and rehabilitation centers, including general and specialized centers. Furthermore, the Company offers hospitalization at home, which avoids or shortens the hospitalization process; and home nursing services, which allows the care prescribes by a doctor at home. Korian-Medicas' establishments are located in France, Italy and Germany via its subsidiaries, Segesta S.p.A., Phonix GmBH, Reacti Malt SAS, Sas La Normandie, Sa La Bastide de la tourne, Sas Mapadex La Roseraie, among others.
Company Coordinates stock-summary
Company Details
Cs 40070, Paris Cedex 17 , PARIS None : 75858
stock-summary
Tel: 33 1 55375200
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Jean-Pierre Duprieu
Chairman of the Board
Mme. Françoise Debrus
Director - Representative of Predica
Mr. Alexandre Gagnon-Kugler
Director - Representative of Investissements PSP
Mr. Jerome Grivet
Director
Mrs. Anne Ramon
Director - Representative of Holding Malakoff Humanis
Mr. Jean-Francois Brin
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
281 Million
(Quarterly Results - Dec 2012)
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 1,367 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.10

stock-summary
Return on Equity

-1.31%

stock-summary
Price to Book

0.38